Charles Legg
Chief Operating Officer at CureLab Oncology, Inc.
Charles Legg active positions
| Companies | Position | Start | End |
|---|---|---|---|
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Chief Operating Officer | - | - |
ZEA Biosciences Corp.
 ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Chief Operating Officer | - | - |
| Secular Student Alliance | Director/Board Member | 2020-12-31 | - |
Career history of Charles Legg
Statistics
International
| United States | 4 |
Operational
| Chief Operating Officer | 2 |
| Director/Board Member | 1 |
Sectoral
| Process Industries | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Process Industries |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
| Secular Student Alliance |
- Stock Market
- Insiders
- Charles Legg
- Experience
